Home / Products / Cancer (Tumor) Cell Lines / Ishikawa
Ishikawa
Datasheet Protocol

Ishikawa

Cat. No. ARC0358
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Uterus (endometrium)

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

Ishikawa is a cancer cell line of uterus (endometrium) adenocarcinoma, isolated from in situ; endometrium.
 
Synonym: ISHIKAWA; ISHI

Recommended Products

CHD9 Knockout K562 Polyclonal Cells CHD9 Knockout K562 Polyclonal Cells Cat. No. ARG19264 OSBPL10 Knockout A549 Polyclonal Cells OSBPL10 Knockout A549 Polyclonal Cells Cat. No. ARG10459 CFAP97 Knockout Hela Polyclonal Cells CFAP97 Knockout Hela Polyclonal Cells Cat. No. ARG8073 ALB Knockout A2780 Polyclonal Cells ALB Knockout A2780 Polyclonal Cells Cat. No. ARG35224 CEBPA Knockout CaSki Polyclonal Cells CEBPA Knockout CaSki Polyclonal Cells Cat. No. ARG9746 NCOA3 Knockout Raji Polyclonal Cells NCOA3 Knockout Raji Polyclonal Cells Cat. No. ARG1598
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Uterus (endometrium)
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
39 years
Derived From Site:
In situ; Endometrium
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

LAMA3 Knockout NCI-H1299 Polyclonal Cells

LAMA3 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG18153
 DCUN1D4 Knockout A549 Polyclonal Cells

DCUN1D4 Knockout A549 Polyclonal Cells

Cat. No. ARG10852
 KIFAP3 Knockout huh-7 Polyclonal Cells

KIFAP3 Knockout huh-7 Polyclonal Cells

Cat. No. ARG28491
 HSPA4 Knockout Hela Polyclonal Cells

HSPA4 Knockout Hela Polyclonal Cells

Cat. No. ARG37520
 ADCK5 Knockout Hela Polyclonal Cells

ADCK5 Knockout Hela Polyclonal Cells

Cat. No. ARG37437
 KANK2 Knockout Hela Polyclonal Cells

KANK2 Knockout Hela Polyclonal Cells

Cat. No. ARG37390